Rocket PharmaceuticalsRCKT
那斯達克 · USD
2.99
-0.06
(-1.97%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Rocket PharmaceuticalsRCKT
2.99
-0.06
(-1.97%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | - | - | - | - | 67,375 | 63,279 | 65,429 | 68,757 | 62,194 | 69,082 |
研發費用 | 35,942 | 37,357 | 42,315 | 46,345 | 45,227 | 41,744 | 46,844 | 51,383 | 46,371 | 50,037 |
推銷及管理費用 | 28,446 | 25,337 | 27,109 | 27,367 | 22,148 | 21,535 | 18,585 | 17,374 | 15,823 | 19,045 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -64,388 | -62,694 | -69,424 | -73,712 | -67,375 | -63,279 | -65,429 | -68,757 | -62,194 | -69,082 |
其他收入及費用 | 3,526 | 2,840 | 3,176 | 4,537 | 5,792 | 4,089 | 3,999 | 3,524 | 4,327 | 2,826 |
利息費用 | 472 | 473 | 471 | 471 | 471 | 470 | 469 | 468 | 468 | 467 |
稅前純益 | -61,334 | -60,327 | -66,719 | -69,646 | -62,054 | -59,660 | -61,899 | -65,701 | -58,335 | -66,723 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -61,334 | -60,327 | -66,719 | -69,646 | -62,054 | -59,660 | -61,899 | -65,701 | -58,335 | -66,723 |
基本每股稅後盈餘(元) | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.73 | -0.89 |
稀釋每股稅後盈餘(元) | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.62 | -0.75 | -0.82 | -0.73 | -0.89 |
基本平均股數(千股) | 110093.00 | 97530.00 | 94158.00 | 93746.00 | 93549.00 | 93336.00 | 82636.00 | 80472.00 | 79453.00 | 76375.00 |
稀釋平均股數(千股) | 110093.00 | 97530.00 | 94158.00 | 93746.00 | 93549.00 | 93336.00 | 82636.00 | 80472.00 | 79453.00 | 76375.00 |
還原基本每股稅後盈餘(元) | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.73 | -0.89 |
還原稀釋每股稅後盈餘(元) | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.62 | -0.75 | -0.82 | -0.73 | -0.89 |
還原基本平均股數(千股) | 110,093 | 97,530 | 94,158 | 93,746 | 93,549 | 93,336 | 82,636 | 80,472 | 79,453 | 76,375 |
還原稀釋平均股數(千股) | 110,093 | 97,530 | 94,158 | 93,746 | 93,549 | 93,336 | 82,636 | 80,472 | 79,453 | 76,375 |
EBITDA(千元) | -59,948 | -58,716 | -65,708 | -69,046 | -62,083 | -60,347 | -61,916 | -65,990 | -58,537 | -65,476 |